Titus B. Ball

Insider · Principal Accounting Officer · ONC

Titus B. Ball files insider transactions with the SEC as a principal accounting officer of BeOne Medicines (ONC). We hold 3 disclosed purchases and sales filed since 4 January 2017, 2 of them in the last 90 days.

Files forONC
Disclosed buys and sells3 in all, 2 in the last 90 days
Last disclosure3 September 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed

Filed 10 June 2025 — 1 September 2026Principal Accounting Officer · BeOne Medicines (ONC)9 Form 4 lines · source: SEC Form 4
Filed 5 June 2024 — 3 September 2024Principal Accounting Officer · BeiGene (BGNE)3 Form 4 lines · source: SEC Form 4
Filed 31 December 2016 — 2 February 2021Chief Accounting Officer · Carlisle Companies (CSL)20 Form 4 lines · source: SEC Form 4

Everything they disclosed

32 entries, newest first — one per disclosure report, one per Form 4 line

▼ sold on the open market 132 shares of BeOne MedicinesSEC Form 43 September 2026American Depositary Shares · traded 1 September 2026 · filed 3 September 2026
was granted 31,213 shares of BeOne MedicinesSEC Form 415 June 2026Ordinary Shares · traded 11 June 2026 · filed 15 June 2026
▼ sold on the open market 49 shares of BeOne MedicinesSEC Form 415 June 2026American Depositary Shares · traded 11 June 2026 · filed 15 June 2026
▼ sold on the open market 120 shares of BeOne MedicinesSEC Form 415 June 2026American Depositary Shares · traded 11 June 2026 · filed 15 June 2026
▼ sold on the open market 100 shares of BeOne MedicinesSEC Form 410 June 2026American Depositary Shares · traded 8 June 2026 · filed 10 June 2026
▼ sold on the open market 36 shares of BeOne MedicinesSEC Form 410 June 2026American Depositary Shares · traded 8 June 2026 · filed 10 June 2026
▼ sold on the open market 122 shares of BeOne MedicinesSEC Form 44 September 2025American Depositary Shares · traded 2 September 2025 · filed 4 September 2025
was granted 29,601 shares of BeOne MedicinesSEC Form 412 June 2025Ordinary Shares · traded 10 June 2025 · filed 12 June 2025
▼ sold on the open market 134 shares of BeOne MedicinesSEC Form 412 June 2025American Depositary Shares · traded 11 June 2025 · filed 12 June 2025
▼ sold on the open market 137 shares of BeiGeneSEC Form 45 September 2024American Depositary Shares · traded 3 September 2024 · filed 5 September 2024
was granted 15,340 shares of BeiGene (a derivative holding)SEC Form 47 June 2024Share Option (Right to Buy) · traded 5 June 2024 · filed 7 June 2024
was granted 24,427 shares of BeiGeneSEC Form 47 June 2024Ordinary Shares · traded 5 June 2024 · filed 7 June 2024
was granted 505 shares of Carlisle CompaniesSEC Form 43 February 2021Common Stock · traded 2 February 2021 · filed 3 February 2021
was granted 2,355 shares of Carlisle Companies (a derivative holding)SEC Form 43 February 2021Employee Stock Option (Right to Buy) · traded 2 February 2021 · filed 3 February 2021
was granted 984 shares of Carlisle CompaniesSEC Form 45 January 2021Common Stock · traded 1 January 2021 · filed 5 January 2021
had shares withheld for tax on 487 shares of Carlisle CompaniesSEC Form 45 January 2021Common Stock · traded 1 January 2021 · filed 5 January 2021
was granted 2,475 shares of Carlisle Companies (a derivative holding)SEC Form 45 February 2020Employee Stock Option (Right to Buy) · traded 4 February 2020 · filed 5 February 2020
was granted 455 shares of Carlisle CompaniesSEC Form 45 February 2020Common Stock · traded 4 February 2020 · filed 5 February 2020
was granted 755 shares of Carlisle CompaniesSEC Form 42 January 2020Common Stock · traded 1 January 2020 · filed 2 January 2020
had shares withheld for tax on 388 shares of Carlisle CompaniesSEC Form 42 January 2020Common Stock · traded 1 January 2020 · filed 2 January 2020
was granted 3,185 shares of Carlisle Companies (a derivative holding)SEC Form 46 February 2019Employee Stock Option (Right to Buy) · traded 5 February 2019 · filed 6 February 2019
was granted 605 shares of Carlisle CompaniesSEC Form 46 February 2019Common Stock · traded 5 February 2019 · filed 6 February 2019
was granted 282 shares of Carlisle CompaniesSEC Form 43 January 2019Common Stock · traded 31 December 2018 · filed 3 January 2019
had shares withheld for tax on 304 shares of Carlisle CompaniesSEC Form 43 January 2019Common Stock · traded 31 December 2018 · filed 3 January 2019
was granted 2,370 shares of Carlisle Companies (a derivative holding)SEC Form 47 February 2018Employee Stock Option (Right to Buy) · traded 6 February 2018 · filed 7 February 2018
was granted 515 shares of Carlisle CompaniesSEC Form 47 February 2018Common Stock · traded 6 February 2018 · filed 7 February 2018
was granted 248 shares of Carlisle CompaniesSEC Form 43 January 2018Common Stock · traded 31 December 2017 · filed 3 January 2018
had shares withheld for tax on 228 shares of Carlisle CompaniesSEC Form 43 January 2018Common Stock · traded 31 December 2017 · filed 3 January 2018
was granted 415 shares of Carlisle CompaniesSEC Form 49 February 2017Common Stock · traded 8 February 2017 · filed 9 February 2017
was granted 1,790 shares of Carlisle Companies (a derivative holding)SEC Form 49 February 2017Common Stock Options · traded 8 February 2017 · filed 9 February 2017
was granted 576 shares of Carlisle CompaniesSEC Form 44 January 2017Common Stock · traded 31 December 2016 · filed 4 January 2017
had shares withheld for tax on 432 shares of Carlisle CompaniesSEC Form 44 January 2017Common Stock · traded 31 December 2016 · filed 4 January 2017

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.